Cigna Group (NYSE:CI – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $340.00 target price on the health services provider’s stock. Cantor Fitzgerald‘s price objective points to a potential upside of 12.70% from the company’s current price.
Other research analysts have also issued reports about the stock. Piper Sandler reaffirmed an “overweight” rating on shares of Cigna Group in a research note on Friday, October 23rd. Evercore assumed coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 target price on the stock. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their target price for the company from $350.00 to $320.00 in a research note on Monday, August 3rd. UBS Group reiterated a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Finally, Barclays raised their price target on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Fourteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $336.40.
View Our Latest Analysis on CI
Cigna Group Trading Down 1.2%
Shares of CI stock opened at $301.67 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $79.71 billion, a price-to-earnings ratio of 9.70, a price-to-earnings-growth ratio of 1.03 and a beta of 0.25. Cigna Group has a 12-month low of $255.53 and a 12-month high of $318.05. The stock’s 50-day moving average price is $285.48 and its 200-day moving average price is $282.05.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating the consensus estimate of $7.52 by $0.46. The business had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the business earned $7.83 earnings per share. Equities research analysts predict that Cigna Group will post 30.49 EPS for the current fiscal year.
Insider Activity
In other news, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.
Institutional Trading of Cigna Group
A number of hedge funds and other institutional investors have recently made changes to their positions in CI. Eurizon Capital SGR S.p.A. lifted its holdings in Cigna Group by 1.8% in the third quarter. Eurizon Capital SGR S.p.A. now owns 106,875 shares of the health services provider’s stock valued at $29,056,000 after acquiring an additional 1,934 shares during the period. Banyan Capital Management Inc. acquired a new stake in shares of Cigna Group during the 3rd quarter worth approximately $17,640,000. Maryland State Retirement & Pension System grew its stake in shares of Cigna Group by 15.9% during the 3rd quarter. Maryland State Retirement & Pension System now owns 16,203 shares of the health services provider’s stock worth $4,404,000 after purchasing an additional 2,225 shares during the period. Illinois Municipal Retirement Fund grew its stake in shares of Cigna Group by 0.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 14,588 shares of the health services provider’s stock worth $3,965,000 after purchasing an additional 86 shares during the period. Finally, Cornerstone Wealth Management LLC increased its holdings in shares of Cigna Group by 3.7% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 1,801 shares of the health services provider’s stock valued at $490,000 after purchasing an additional 65 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Cigna Group News Summary
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Q3 adjusted EPS was $7.98, ahead of analyst estimates, and revenue rose about 6% year over year to $73.79 billion, also exceeding consensus. Cigna cited strength in its healthcare businesses and a favorable drug mix. Read More.
- Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share, reinforcing the view that operating performance is improving. Read More.
- Positive Sentiment: Cigna also outlined longer-term targets, including 10%–14% adjusted EPS growth and roughly $50 billion in cumulative operating cash flow through 2030. Its $3 billion “Accelerate to One” initiative is intended to improve productivity and modernize operations. Read More.
- Neutral Sentiment: The planned ACA market exit may simplify Cigna’s business focus, but it also marks a change in its health-insurance footprint. The impact will depend on how the company manages the transition. Read More.
- Negative Sentiment: GAAP net income was $1.44 billion, down from $1.87 billion a year earlier, and reported EPS declined to $5.47 from $6.98. That contrasts with the stronger adjusted results and may temper the headline earnings beat. Read More.
Cigna Group Company Profile
The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.
The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.
Featured Stories
- Five stocks we like better than Cigna Group
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
